Why Molina Healthcare Is On Investors’ Radar Today

Molina Healthcare (MOH) has drawn investor attention after a period where the share price shows mixed returns, with gains over the month but weaker performance over the past 3 months and year.

The recent 18.94% 1-month share price return suggests some momentum is coming back into the stock, although the 16.40% year-to-date share price decline and 52.04% 1-year total shareholder return loss show sentiment has been under pressure for a while.

If Molina Healthcare’s moves have you rethinking your watchlist, this could be a good moment to scout 34 healthcare AI stocks as potential next ideas in the healthcare space.

With Molina trading at US$149.19, an intrinsic value gap of roughly 86% and only a small 3% discount to the average analyst target, you have to ask: is this a genuine value opportunity, or is the market already factoring in its future growth?

Most Popular Narrative: 63.8% Undervalued

Compared with Molina Healthcare’s last close at $149.19, the most followed narrative prices fair value much higher, which is what drives the strong undervaluation call that follows.

Catalysts

• Membership Growth: MOH has seen a 9% increase in members year over year, reaching approximately 5.7 million members as of March 31, 2024. This growth is driven by new contract wins, acquisitions, and expansion.

That 63.8% discount rests on more members, richer premium inflows, and improving profitability. Curious which growth and margin assumptions power a fair value above $400?

Result: Fair Value of $411.65 (UNDERVALUED)

However, those upside assumptions can be knocked off course if regulatory changes squeeze Medicaid or Medicare economics, or if medical costs run hotter than expected.

Next Steps

With mixed sentiment running through this story and both risks and rewards in play, it makes sense to move quickly, review the underlying data yourself, and weigh up 3 key rewards and 1 important warning sign before deciding what it all means for you.

Looking For More Investment Ideas?

If Molina has sharpened your focus, do not stop here. Use the screener to quickly surface other opportunities that might fit your style and risk comfort.

• Target potential mispricings by scanning our list of 47 high quality undervalued stocks that could be worth a closer look before the crowd catches on.
• Prioritize resilience by checking out a solid balance sheet and fundamentals stocks screener (41 results) that may handle shocks better than more fragile names.
• Hunt for off the radar potential by reviewing a screener containing 25 high quality undiscovered gems that many investors might not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.